The FDA assessed the security and usefulness of atidarsagene autotemcel determined by details from 37 kids who acquired atidarsagene autotemcel in two solitary-arm, open up-label medical trials As well as in an expanded entry method.[seven] Children who obtained remedy with atidarsagene autotemcel were being compared to untreated little ones (pure